secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2022-03-02T23:59:59+00:00
Accession:  0001654954-22-002417
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Peter van der Velden resigns from Edesa Biotech board effective Feb 28, 2022
--------------------------------------------------------------------------------

- Peter van der Velden resigned as director effective Feb 28, 2022; he had served since 2015.
- Departure is not due to any disagreement with the company's operations, policies, or procedures.
- His firm remains an investor in Edesa Biotech.
- Nominating and governance committee (chaired by van der Velden) engaged a search firm to evaluate board composition and diversity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495422002417/0001654954-22-002417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495422002417/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-002417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer